Monday, January 26, 2009

Live Blogging the Pfizer-Wyeth Analyst Call

After the deal, Pfizer said that no drug will account for more than 10% of its revenue in 2012.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)